# Abdominal Wall Local Anesthesia to Maximize Postoperative Pain Control After Cesarean Delivery

> **NCT01261637** · PHASE4 · COMPLETED · sponsor: **IWK Health Centre** · enrollment: 86 (actual)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** Saline placebo
- **DRUG:** Ropivicaine

## Key facts

- **NCT ID:** NCT01261637
- **Lead sponsor:** IWK Health Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2010-07
- **Final completion:** 2011-01
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2013-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01261637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01261637, "Abdominal Wall Local Anesthesia to Maximize Postoperative Pain Control After Cesarean Delivery". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01261637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*